The mechanism of action, pharmacokinetics, and clinical efficacy of carfilzomib for the treatment of multiple myeloma

Author： Pautasso Chiara   Bringhen Sara   Cerrato Chiara   Magarotto Valeria   Palumbo Antonio  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.10, 2013-10, pp. : 1371-1379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carfilzomib: In Relapsed, or Relapsed and Refractory, Multiple Myeloma

By McCormack Paul L.  

Drugs, Vol. 72, Iss. 15, 2012-10 ,pp. : 2023-2032

Adis International

Access to resources Recommend Favorite

A Threshold Regression Mixture Model for Assessing Treatment Efficacy in a Multiple Myeloma Clinical Trial

By Lee Mei-Ling Ting  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 6, 2008-11 ,pp. : 1136-1149

Taylor & Francis Ltd

Access to resources Recommend Favorite

Panobinostat for the treatment of multiple myeloma

By Neri Paola   Bahlis Nizar J   Lonial Sagar  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 733-747

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of the pharmacokinetics, preclinical and clinical efficacy of pralatrexate for the treatment of T-cell lymphoma

By Foss Francine M  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1141-1152

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections

By Kuti Effie L   Kuti Joseph L  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 10, 2010-10 ,pp. : 1287-1300

Informa Healthcare

Access to resources Recommend Favorite